Rossmore Private Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,398
Closed -$219K 330
2025
Q2
$219K Buy
2,398
+6
+0.3% +$580 0.03% 241
2025
Q1
$271K Buy
2,392
+82
+4% +$8.77K 0.03% 217
2024
Q4
$244K Hold
2,310
0.03% 220
2024
Q3
$249K Hold
2,310
0.03% 221
2024
Q2
$251K Hold
2,310
0.03% 213
2024
Q1
$305K Hold
2,310
0.04% 204
2023
Q4
$281K Hold
2,310
0.04% 203
2023
Q3
$259K Hold
2,310
0.04% 202
2023
Q2
$336K Hold
2,310
0.05% 186
2023
Q1
$298K Hold
2,310
0.05% 193
2022
Q4
$295K Hold
2,310
0.05% 194
2022
Q3
$242K Hold
2,310
0.04% 200
2022
Q2
$243K Hold
2,310
0.04% 201
2022
Q1
$295K Sell
2,310
-69
-3% -$8.32K 0.05% 194
2021
Q4
$293K Hold
2,379
0.05% 194
2021
Q3
$338K Hold
2,379
0.06% 179
2021
Q2
$371K Hold
2,379
0.06% 171
2021
Q1
$370K Hold
2,379
0.07% 166
2020
Q4
$356K Buy
2,379
+10
+0.4% +$1.41K 0.07% 163
2020
Q3
$313K Buy
2,369
+309
+15% +$40.4K 0.07% 155
2020
Q2
$239K Buy
+2,060
New +$237K 0.07% 155
2018
Q1
Sell
-15
Closed -$1.81K 413
2017
Q4
$1.81K Buy
+15
New +$1.7K ﹤0.01% 414

Other funds holding ZBH

Rossmore Private Capital's ZBH Position: Q3 2025 in Review

Rossmore Private Capital sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 2,398 shares — an estimated $219K sold.

Rossmore Private Capital first reported a position in ZBH in Q4 2017 and held it in 22 quarters. The position peaked at $371K in Q2 2021. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

  • Rossmore Private Capital reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
  • Rossmore Private Capital sold 2,398 Zimmer Biomet shares in Q3 2025, an estimated $219K.
  • Rossmore Private Capital first reported a position in Zimmer Biomet in Q4 2017 and held it in 22 quarters.
  • Rossmore Private Capital's Zimmer Biomet position peaked at $371K in Q2 2021.
  • 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Rossmore Private Capital's 13F filing for Q3 2025, filed 30 Oct 2025.